Desmoplastic and spindle-cell malignant melanoma: An immunohistochemical study

American Journal of Surgical Pathology

Volumn 20, Issue 12, 1996, Pages 1489-1500

  Longacre, Teri A ^a   Egbert, Barbara M ^b   Rouse, Robert V ^a,b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Desmoplastic melanoma; S100 HMB45 Actin Immunohistology; Spindle cell melanoma

Indexed keywords

ACTIN FILAMENT; ARTICLE; CELL ISOLATION; CELL POPULATION; DERMOEPIDERMAL JUNCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MELANOMA; MYOFIBROBLAST; SKIN PIGMENTATION; SPINDLE CELL; SUN EXPOSURE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0029797137     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199612000-00008     Document Type: Article

References (40)

1. Anstey A, Cerio R, Ramnarain N, Orchard G, Smith N, Wilson-Jones E. Desmoplastic malignant melanoma: an immunocytochemical study of 25 cases. Am J Dermatopathol 1994;16:14-22.
2. Anstey A, McKee P, Wilson-Jones E. Desmoplastic malignant melanoma: a clinicopathological study of 25 cases. Br J Dermatol 1993;129:359-71.
3. Beenken S, Byers R, Smith JL, Goepfert H, Shallenberger R. Desmoplastic melanoma: histologic correlation with behavior and treatment. Arch Otolaryngol Head Neck Surg 1989;115:374-9.
4. Binder SW, Said JW, Shintaku IP, Pinkus GS. A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma: use of monoclonal antibody KP-1 (CD68). Am J Clin Pathol 1992; 97:759-63.
5. Bishop PW, Menasce LP, Yates AJ, Win NA, Banerjee SS. An immunophenotypic survey of malignant melanomas. Histopathology 1993;23:159-66.
6. Bruijn JA, Mihm MC. Barnhill RL. Desmoplastic melanoma. Histopathology 1992;20:197-205.
7. Conley J, Lattes R, Orr W. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer 1971;28:914-36.
8. Duray PH, Palazzo J, Gown AM, Ohuchi N. Melanoma cell heterogeneity: a study of two monoclonal antibodies compared with S-100 protein in paraffin sections. Cancer 1988;61:2460-8.
9. Egbert B, Kempson R, Sagebiel R. Desmoplastic malignant melanoma: a clinicohistopathologic study of 25 cases. Cancer 1988;62: 2033-41.
10. Facchetti F, Bertalot G, Grigolato PG. KP1 (CD68) staining of malignant melanomas. Histopathology 1991;19:141-5.
11. From L, Hanna W, Khan HJ, Gruss J, Marks A, Baumal R. Origin of the desmoplasia in desmoplastic malignant melanoma. Hum Pathol 1983;14:1072-80.
12. Giangaspero F, Fratamico FC, Ceccavelli C, Brisigotti M. Malignant peripheral nerve sheath tumors and spindle cell sarcomas: an immunohistochemical analysis of multiple markers. Appl Pathol 1989;7:134-44.
13. Gloghini A, Volpe R, Canzonieri V, Carbone A. Immunohistochemical characterization of Ki-M6 monoclonal antibody in Bouin-fixed, paraffin-embedded sections of normal and neoplastic human tissues. Virchows Arch A Pathol Anal Histopathol 1991; 418:355-60.
14. Gown AM, Vogel AM, Hoak D, Gough F. McNutt MA. Monoclonal antibodies specific for melanocytic tumors distinguish sub-populations of melanocytes. Am J Parhol 1986;123:195-203.
15. Jain S, Allen PW. Desmoplastic malignant melanoma and its variants: a study of 45 cases. Am J Surg Pathol 1989;13:358-73.
16. Kahn HJ, Marks A, Thom H, Baumal R. Role of antibody to S100 protein in diagnostic pathology. Am J Clin Pathol 1983;79:341-7.
17. Kossard S, Doherty E, Murray E. Neurotropic melanoma: a variant of desmoplastic melanoma. Arch Dermatol 1987;123:907-12.
18. Labrecque PG, Hu C-H, Winkelmann RK. On the nature of desmoplastic melanoma. Cancer 1976;38:1205-13.
19. Leong AS, Wannakrairot P. A retrospective analysis of immunohistochemical staining in identification of poorly differentiated round cell and spindle cell tumors - results, reagents and costs. Pathology 1992;4:254-60.
20. Longacre TA, Smoller BR, Rouse RV. Atypical fibroxanthoma: multiple immunohistologic profiles. Am J Surg Pathol 1993;17: 1199-209.
21. Ma CK, Zarbo RJ, Gown AM. Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans. Am J Clin Pathol 1992;97:478-83.
22. Meis JM, Enzinger FM, Martz KL, Neal JA. Malignant peripheral nerve sheath tumors (malignant schwannomas) in children. Am J Surg Pathol 1992;16:694-707.
23. Ordonez NG, Xiaolong J, Hickey RC. Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma. Am J Clin Pathol 1988;90:385-90.
24. Reed RJ, Leonard DD. Neurotropic melanoma: A variant of desmoplastic melanoma. Am J Surg Pathol 1979;3:301-11.
25. Reiman HM, Goellner JR, Woods JE, Mixter RC. Desmoplastic melanoma of the head and neck. Cancer 1987;60:2269-74.
26. Ricci Jr A, Cartun RW, Zakowski MF. Atypical fibroxanthoma: a study of 14 cases emphasizing the presence of Langerhans' histiocytes with implications for differential diagnosis by antibody panels. Am J Surg Pathol 1988;8:591-8.
27. Selby WL, Nance KV, Park HK. CEA immunoreactivity in metastatic malignant melanoma. Mod Pathol 1992;5:415-9.
28. Silvis NG, Swanson PE, Manivel JC, Kaye VN, Wick MR. Spindle-cell and pleomorphic neoplasms of the skin: a clinicopathologic and immunohistochemical study of 30 cases, with emphasis on "atypical fibroxanthomas." Am J Dermatopathol 1988;10: 9-19.
29. Skelton HG, Smith KJ, Laskin WB, et al. Desmoplastic malignant melanoma. J Am Acad Dermatol 1995;32:717-25.
30. Skelton HG, Smith KJ, Laskin W, Graham JH, Lupton GP. Desmoplastic malignant melanoma. J Cutan Pathol 1990;17:317.
31. Springall DR, Gu J, Cocchia D, et al. The value of S-100 immunostaining as a diagnostic tool in human malignant melanomas: a comparative study using S-100 and neuron-specific enolase antibodies. Virchows Arch Pathol Anal 1983;400:331-43.
32. Tsukamoto H, Mishima K, Hayashibe K, Sasase A. Alpha-smooth muscle actin expression in tumor and stromal cells of benign and malignant human pigment cell tumors. J Invest Dermatol 1992;98 116-20.
33. Valensi QJ. Desmoplastic malignant melanoma: a light and electron microscopic study of two cases. Cancer 1979;43:1148-155.
34. van de Rijn M, Rouse RV. CD34: a review. Appl Immunohistochem 1994;2:71-80.
35. Vennegoor C, Calafat J, Hageman P, et al. Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/ C-3. Int J Cancer 1985;35:287-95.
36. Walsh NMG, Roberts JR, Orr W, Simon GT. Desmoplastic malignant melanoma: a clinicopathologic study of 14 cases. Arch Pathol Lab Med 1988;112:922-7.
37. Warner TFCS, Lloyd RV, Hafez GR, Angevine JM. Immunocytochemistry of neurotropic melanoma. Cancer 1984;53:254-7.
38. Weiss SW, Nickoloff BJ. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 1993;17:1039-45.
39. Whitaker DC, Argenyi Z, Smith AC. Desmoplastic malignant melanoma: rare and difficult to diagnose. J Am Acad Dermatol 1992;26:704-9.
40. Wick MR, Swanson PE, Rocamora A. Recognition of malignant melanoma by monoclonal antibody HMB-45: an immunohistochemical study of 200 paraffin-embedded cutaneous tumors. J Cutan Pathol 1988;15:201-7.